HDMA Sees Reimportation In 2005 Regardless Of Presidential Election Results
This article was originally published in The Pink Sheet Daily
Executive Summary
Rx importation will "come to pass one way or another," Healthcare Distribution Management Association CEO John Gray says. An association-commissioned report is designed to demonstrate the value of distributors in the pharmaceutical supply chain.
You may also be interested in...
Medicare Rx, Drug Importation Among HDMA Annual Meeting Topics
FDA Assistant Commissioner for Legislative Affairs Patrick Ronan and Senate Health Committee Counsel Steve Irizarry are scheduled speakers at the Healthcare Distribution Management Association meeting Nov. 3-6.
Medicare Rx, Drug Importation Among HDMA Annual Meeting Topics
FDA Assistant Commissioner for Legislative Affairs Patrick Ronan and Senate Health Committee Counsel Steve Irizarry are scheduled speakers at the Healthcare Distribution Management Association meeting Nov. 3-6.
Canadian Rx Imports Would Supply 10% Of U.S. Market, Caremark Exec Says
The limited supply of drugs coming from Canada under a legalized importation system would have little impact on U.S. prices, Caremark CEO Crawford says at PCMA annual meeting. Importation would require PBMs to decide how to distribute lower-priced Canadian products among their clients, he says.